NCT05676411

Brief Summary

The goal of this prospective randomized clinical trial is to investigate the potential synergistic effect of combination of topical benzoyl peroxide and making skin incision with electrocautery on preventing surgical wound contamination from Cutibacterium acnes (C. acnes) in patients undergoing shoulder replacement. The main question it aims to answer is: • Will the combined use of topical application of benzoyl peroxide and making skin incision using electrocautery decrease the positive culture rates of C. acnes in the surgical field? Participants will be asked to apply topical benzoyl peroxide to the shoulder skin prior to their shoulder replacement surgery if they are randomized in the treatment group. The skin incision will be made using electrocautery in both the control and treatment groups. Microbiology swab cultures will be taken during shoulder replacement surgery to compare the positive culture rates for C. acnes between the groups.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

December 22, 2022

Last Update Submit

July 12, 2024

Conditions

Keywords

Shoulder arthroplastyProsthetic joint infectionCutibacterium acnesBenzoyl peroxideElectrocautery

Outcome Measures

Primary Outcomes (1)

  • Late dermis C. acnes culture rates

    Positive C. acnes culture rates from samples taken from the incised dermis during the later part of shoulder replacement

    Within 14 days of shoulder replacement surgery

Secondary Outcomes (1)

  • Mid-procedure synovium C. acnes culture rates

    Within 14 days of shoulder replacement surgery

Study Arms (2)

Electrocautery-incision alone group

ACTIVE COMPARATOR

The skin inicsion will be made using electrocautery during shoulder replacement in patients assigned this group with no other preoperative treatment.

Procedure: Electrocautery surgical skin incision

Electrocautery-incision and BPO group

EXPERIMENTAL

Patients assigned in this group will undergo an application of topical benzoyl peroxide to the shoulder skin prior to shoulder replacement surgery in addition to their skin incision being made using electrocautery.

Drug: Benzoyl Peroxide TopicalProcedure: Electrocautery surgical skin incision

Interventions

Topical benzoyl peroxide cream will be applied to the shoulder skin twice a day for 2 days leading up to and in the morning of surgery.

Electrocautery-incision and BPO group

The skin incision will be made entirely using electrocautery at the beginning of shoulder replacement.

Electrocautery-incision alone groupElectrocautery-incision and BPO group

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult male patients (\>18 years old) who will undergo primary shoulder arthroplasty (either anatomic or reverse) secondary to osteoarthritis, cuff tear arthropathy, or massive irreparable rotator cuff tear.

You may not qualify if:

  • History of ipsilateral open shoulder procedures
  • History of ipsilateral shoulder infection (either native or postoperative infection)
  • Intake of any preoperative antibiotics within one month prior to index surgery
  • Active acne at surgical site
  • History of psoriatic or eczematous lesions to the surrounding shoulder region
  • History of allergic reactions to benzoyl peroxide
  • Planned for revision arthroplasty surgery
  • Minors under the age of 18 years old
  • Female patients
  • Prisoners
  • Workers compensation insurance status
  • Surgery planned for acute proximal humerus fracture or fracture sequelae (nonunion or malunion)
  • Patients who cannot understand English well enough to adequately provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Interventions

Benzoyl Peroxide

Intervention Hierarchy (Ancestors)

BenzoatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Officials

  • Hyunmin M Kim, MD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 22, 2022

First Posted

January 9, 2023

Study Start

June 1, 2024

Primary Completion

July 30, 2025

Study Completion

August 30, 2025

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Individual patients' deidentified demographic information (age and sex only) and microbiology culture results can be shared with other researchers upon request

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
From May 2023 to May 2025

Locations